NeuroFlow Closes $20M Series B Investment

NeuroFlow announced the initial closing of a $20M Series B financing round led by Magellan Health, in addition to a syndicate including previous investors. Magellan manages the fast growing, complex areas of health, including behavioral health, complete pharmacy benefits and other specialty areas of healthcare.

NeuroFlow will use the Series B proceeds to scale operations and support its growth in data analytics, artificial intelligence, and direct health record integrations. NeuroFlow’s contracted user base has grown 10x to over 330,000 in support of nearly 200 commercial health systems, payers, accountable care organizations, independent medical groups, and federal agencies to . . .